Orchestra BioMed Bioelectronic Therapies
Presence
Orchestra BioMed Bioelectronic Therapies is owned by Orchestra BioMed.
Executives
View the org chart displaying its 5 main executives
Most searched biographies at Orchestra BioMed Bioelectronic Therapies
- Yuval Mika, General Manager
- Ziv Belsky, Vice President, Research & Development
- Stephen Zielinski, Vice President, Product Development
Popular executive movements at Orchestra BioMed
- David Pacitti has joined the company as Director (posted on March 26 2024).
Create your alert
to follow the executive moves at Orchestra BioMed Bioelectronic Therapies.
Biotechnology
Orchestra BioMed has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Orchestra BioMed Bioelectronic Therapies
- News Releases | Orchestra BioMed
- Clinical Data Presented at ESC Congress Show BackBeat Medical's Cardiac Pacing-Based Treatment for Hypertension Produces Significant, Sustained Reductions in Blood Pressure
- BackBeat Medical Wins Top Honor in TCT 2016 Shark Tank Innovation Competition
- Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)
- Biomedical Innovation News & Events | Orchestra BioMed
Social media about Orchestra BioMed Bioelectronic Therapies
- Orchestra BioMed Bioelectronic Therapies on Wikipedia, Google News & Yahoo Finance
- Orchestra BioMed Bioelectronic Therapies on LinkedIn, Twitter & YouTube
